Showing 751-760 of 1520 results for "".
- FDA Approves New HA Gels From Evolushttps://modernaesthetics.com/news/fda-approves-new-ha-gels-from-evolus/2473740/The US Food and Drug Administration has approved Evolysse™ Form and Evolysse™ Smooth injectable hyaluronic acid (HA) gels, the first two products in the Evolysse™ collection, Evolus announced. These approvals mark Evolus’ entry into the United States HA dermal filler
- Utah Surgeon's LumipenPro Enlists Archetype to Pursue EU MDR Approvalhttps://modernaesthetics.com/news/utah-surgeons-lumipenpro-enlists-archetype-to-pursue-eu-mdr-approval/2473738/Medtech innovation management consultancy Archetype has been appointed to drive the European Medical Device Regulation (EU MDR) approval process for LumipenPro™, a medical illumination device designed to enhance precision and efficiency during aesthetic surgical procedures where visibility
- Legal Expert Discusses Industry Outlook for 2025https://modernaesthetics.com/news/legal-expert-discusses-industry-outlook-for-2025/2473729/As a partner in the law firm Michelman & Robinson's Commercial & Business Litigation Practice, Madison Dini has a well-informed perspective on the medical industry. Among other trends, Dini expects an uptick in mergers and acquisitions (M&A) activity within medtech and aesthetics
- Elevai Skincare Inc. Acquired by Bio-Aesthetics Company Carmellhttps://modernaesthetics.com/news/elevai-skincare-inc-acquired-by-bio-aesthetics-company-carmell/2473723/Carmell Corporation, a bio-aesthetics company focused on skin and hair health, announced in a press release that it entered into a definitive purchase agreement with PMGC Holdings Inc. (formerly Elevai Labs Inc.) and its wholly owned subsidiary, Elevai Skincare Inc., to acquire the assets related
- Report: Regenerative Aesthetics Exosome Market Poised for Growth Through 2031https://modernaesthetics.com/news/report-regenerative-aesthetics-exosome-market-poised-for-growth-through-2031/2473722/The global regenerative aesthetics exosome products market is projected to experience a compound annual growth rate (CAGR) of 35.5% from 2024 to 2031, according to a report from InsightAce Analytic. Exosome-based therapies with applications in skin reju
- Elevai Labs Inc. Announces Anticipated Name Change to PMGC Holdings Inc.https://modernaesthetics.com/news/elevai-labs-inc-announces-anticipated-name-change-to-pmgc-holdings-inc/2473721/Elevai Labs Inc. is changing its name to PMGC Holdings Inc., the company announced Friday. A press release also stated that PMGC Holdings Inc. plans to effectuate a strategic reorganization effective on Dec. 20. Along with the name change, the reorganization includes moving from D
- Recent Wall Street Journal Article “Belittles” Efforts of Dermatologists, Dr. Doris Dayhttps://modernaesthetics.com/news/recent-wall-street-journal-article-belittles-efforts-of-dermatologists-dr-doris-day/2473719/Modern Aesthetics Editorial Board member Doris Day, MD, FAAD, didn’t hold back when speaking out against a recent Wall Street Journal article portraying dermatology as a cushiony specialty and citing that as a reason it is gaining increasing traction from me
- The Aesthetic Society Announces Major Milestone, New Educational Opportunitieshttps://modernaesthetics.com/news/the-aesthetic-society-announces-major-milestone-new-educational-opportunities/2473711/The Aesthetic Society announced a “historic” expansion of its Global Alliance Partners program on Tuesday. The society has secured partnerships with 31 distinguished international aesthetic surgery organizations through Memorandum of Understanding (MOU) agreements. &qu
- DefenAge Skincare Launches 12-Factor Revitalizing Lip Enhancerhttps://modernaesthetics.com/news/defenage-skincare-launches-12-factor-revitalizing-lip-enhancer/2473701/DefenAge Skincare introduces a “revolutionary, first-of-its kind” anti-aging serum for fuller, smoother and more youthful lips. The 12-Factor Revitalizing Lip Enhancer is powered by DefenAge’s patented Age-Repair Defensins. The lip serum is designed to rejuvenate lip a
- JOYA Launches First Skin Cancer Prevention, Anti-Aging Employee Benefit Platformhttps://modernaesthetics.com/news/joya-launches-first-skin-cancer-prevention-anti-aging-employee-benefit-platform/2473695/JOYA the first employee skin health and wellness benefit platform, announced its emergence from stealth mode with $5 million in seed funding from LUX Capital, Mosaic General Partnership, Arsama Trust, and Joyance Partners. The funding will support team expansion, product developme